Hospira—Carpuject Syringes Containing Morphine Sulfate for Injection: May Contain Greater-than-Intended Fill Volume

April 25, 2012 | Strategic Insights for Health System


ECRI Institute’s complete weekly summary of medical device hazard and recall information is available in ECRI Institute’s Health Devices Alerts(HDA). For more information about HDA, contact us at clientservices@ecri.org.

In an April 17, 2012, Press Release posted by FDA and in an April 18, 2012, Urgent Drug Recall letter, Hospira states that it has received reports of the syringes below containing a greater-than-intended fill level of morphine sulfate, potentially leading to patient overdose. Morphine overdose may cause respiratory depression (slowed or suspended breathing) and low blood...

Access Full Content

Contact us today at 610.825.6000.